A simple and universal enzyme-free approach for the detection of multiple microRNAs using a single nanostructured enhancer of surface plasmon resonance imaging.


Journal

Analytical and bioanalytical chemistry
ISSN: 1618-2650
Titre abrégé: Anal Bioanal Chem
Pays: Germany
ID NLM: 101134327

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 06 06 2018
accepted: 16 08 2018
revised: 22 07 2018
pubmed: 30 8 2018
medline: 23 5 2019
entrez: 30 8 2018
Statut: ppublish

Résumé

Here we describe a simple approach for the simultaneous detection of multiple microRNAs (miRNAs) using a single nanostructured reagent as surface plasmon resonance imaging (SPRi) enhancer and without using enzymatic reactions, sequence specific enhancers or multiple enhancing steps as normally reported in similar studies. The strategy involves the preparation and optimisation of neutravidin-coated gold nanospheres (nGNSs) functionalised with a previously biotinylated antibody (Ab) against DNA/RNA hybrids. The Ab guarantees the recognition of any miRNA sequence adsorbed on a surface properly functionalised with different DNA probes; at the same time, gold nanoparticles permit to detect this interaction, thus producing enough SPRi signal even at a low ligand concentration. After a careful optimisation of the nanoenhancer and after its characterisation, the final assay allowed the simultaneous detection of four miRNAs with a limit of detection (LOD) of up to 0.5 pM (equal to 275 attomoles in 500 μL) by performing a single enhancing injection. The proposed strategy shows good signal specificity and permits to discriminate wild-type, single- and triple-mutated sequences much better than non-enhanced SPRi. Finally, the method works properly in complex samples (total RNA extracted from blood) as demonstrated by the detection of four miRNAs potentially related to multiple sclerosis used as case study. This proof-of-concept study confirms that the approach provides the possibility to detect a theoretically unlimited number of miRNAs using a simple protocol and an easily prepared enhancing reagent, and may further facilitate the development of affordable multiplexing miRNA screening for clinical purposes.

Identifiants

pubmed: 30155701
doi: 10.1007/s00216-018-1331-0
pii: 10.1007/s00216-018-1331-0
doi:

Substances chimiques

Enzymes 0
Indicators and Reagents 0
Ligands 0
MicroRNAs 0
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1873-1885

Subventions

Organisme : Ministerio de Educación, Cultura y Deporte
ID : FPU014/06249
Organisme : EuroNanoMedII
ID : NanoplasmiRNA

Auteurs

Andrea Sguassero (A)

Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Álvaro Artiga (Á)

Instituto de Ciencia de Materiales de Aragon (CSIC-Universidad de Zaragoza), 50009, Zaragoza, Spain.
Centro de Investigacion Biomedica en Red in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029, Madrid, Spain.

Carlo Morasso (C)

Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Rafael Ramirez Jimenez (RR)

Instituto de Ciencia de Materiales de Aragon (CSIC-Universidad de Zaragoza), 50009, Zaragoza, Spain.
Centro de Investigacion Biomedica en Red in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029, Madrid, Spain.

Rafael Martín Rapún (RM)

Instituto de Nanociencia de Aragón (INA), Universidad de Zaragoza, Campus Rio Ebro, Edificio I+D, INA, C/Mariano Esquillor s/n, 50018, Zaragoza, Spain.

Roberta Mancuso (R)

Laboratory of Molecular Medicine and Biotechnologies, IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Simone Agostini (S)

Laboratory of Molecular Medicine and Biotechnologies, IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Ambra Hernis (A)

Laboratory of Molecular Medicine and Biotechnologies, IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Arturs Abols (A)

Latvian Biomedical Research and Study Centre, Riga, 1067, Latvia.

Aija Linē (A)

Latvian Biomedical Research and Study Centre, Riga, 1067, Latvia.

Alice Gualerzi (A)

Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Silvia Picciolini (S)

Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.
Nanomedicine Center NANOMIB, School of Medicine and Surgery, University of Milano-Bicocca, 20900, Monza, Italy.

Marzia Bedoni (M)

Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Marco Rovaris (M)

Multiple Sclerosis Unit, IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Furio Gramatica (F)

Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy.

Jesus M de la Fuente (JM)

Instituto de Ciencia de Materiales de Aragon (CSIC-Universidad de Zaragoza), 50009, Zaragoza, Spain. jmfuente@unizar.es.
Centro de Investigacion Biomedica en Red in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029, Madrid, Spain. jmfuente@unizar.es.

Renzo Vanna (R)

Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Carlo Gnocchi, 20121, Milan, Italy. renzo.vanna@icsmaugeri.it.
Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 10, 27100, Pavia, Italy. renzo.vanna@icsmaugeri.it.

Articles similaires

High-throughput Bronchus-on-a-Chip system for modeling the human bronchus.

Akina Mori, Marjolein Vermeer, Lenie J van den Broek et al.
1.00
Humans Bronchi Lab-On-A-Chip Devices Epithelial Cells Goblet Cells
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition

The significance of miR-124 in the diagnosis and prognosis of glioma: A systematic review.

Elham Ghasemi, Mahdieh Mondanizadeh, Amir Almasi-Hashiani et al.
1.00
Humans MicroRNAs Glioma Prognosis Biomarkers, Tumor

Classifications MeSH